Chemical Compound

Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-; 4-(1,1-Dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide; ACT 434964; Actelion; Bosentan; Ro 47-0203; Ro 47-0203/039; Tracleer; p-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide

CAS Registry Number 147536-97-8
返回搜索 申请报价
Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-; 4-(1,1-Dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide; ACT 434964; Actelion; Bosentan; Ro 47-0203; Ro 47-0203/039; Tracleer; p-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide 结构式
Primary record

Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-; 4-(1,1-Dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide; ACT 434964; Actelion; Bosentan; Ro 47-0203; Ro 47-0203/039; Tracleer; p-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide

库存
8,859 克
纯度
98.3 %
CAS
147536-97-8

化合物标识与属性

CAS
147536-97-8
PubChem CID
104865
SMILES
CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC
Canonical SMILES
COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)(C)C)cc2)nc(-c2ncccn2)nc1OCCO

名称与同义词

  • Bosentan
  • Tracleer
  • 147536-97-8
  • Bosentan hydrate
  • Actelion
  • bosentanum
  • bosentan anhydrous
  • bosentan monohydrate
  • Anhydrous bosentan
  • stayveer
  • Bosentan (INN)
  • Bosentan-d4
  • Tracleer (TN)
  • Bosentan (Standard)
  • Bosentan [USAN:INN:BAN]
  • C27H29N5O6S
  • starbld0043886
  • CHEMBL957
  • BOSENTAN [INN]
  • Ro 47-0203
  • BOSENTAN [MI]
  • RefChem:121072
  • Ro-47-0203
  • UNII-XUL93R30K2
  • XUL93R30K2
  • Bosentan (as monohydrate)
  • DTXSID7046627
  • BOSENTAN [WHO-DD]
  • D0U4CE
  • AC1L2XN2
  • SCHEMBL4218
  • DTXCID5026627
  • Bosentan - Bio-X trade mark
  • CHEBI:51450
  • GTPL3494
  • orb1300924
  • SCHEMBL29485039
  • CTK4D4929
  • HY-A0013R
  • C02KX01
  • 4-BENZOYL-3-NITROPYRIDINE
  • GJPICJJJRGTNOD-UHFFFAOYSA-N
  • MFCD00867375
  • MFCD09751188
  • GLXC-03123
  • HMS2090N14
  • HMS3652F15
  • HMS3715N05
  • HMS3750A13
  • 147536-97-8 (free)
  • Ro 47-0203/039
  • Ro-47-0203/029
  • BCP05202
  • HY-A0013
  • KS-5062
  • ZINC1538857
  • Tox21_112444
  • ABP001094
  • AC-148
  • BDBM50061101
  • C27-H29-N5-O6-S
  • CID104865
  • EBC-06096
  • MSK168227
  • NCGC00167440-01
  • PDSP1_001731
  • PDSP2_001714
  • s4220
  • AKOS015852063
  • Tox21_112444_1
  • ACN-048487
  • AM84442
  • BCP9000445
  • CCG-221182
  • CS-0381
  • DB00559
  • p-tert-Butyl-N-[6-(2-hydroxyethoxy)
  • Ro 470203
  • Ro-470203029
  • SB17356
  • VA10428
  • NCGC00167440-02
  • Ro 47 0203
  • AN-16081
  • BB164259
  • DA-71682
  • EN002863
  • LS-31532
  • p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide
  • R134
  • Ro 47-0203/029
  • Ro-47-0203-029
  • Ro-47-0203/039
  • SC-19679
  • 4-(tert-butyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide
  • 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide
  • AB0018010
  • Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-
  • J594.472D
  • TL8001039
  • B1682
  • B5118
  • CAS-147536-97-8
  • FT-0658809
  • NS00008194
  • Q326023R30
  • SW199648-3
  • A11091
  • D07538
  • EN300-120648
  • W-5165
  • W18800
  • AB01275536-01
  • 144096-EP2287165A2
  • 144096-EP2287166A2
  • 144096-EP2292620A2
  • 212B550
  • A808658
  • L001086
  • Q419769
  • SR-05000001532
  • 157212-55-0
  • 174227-18-0
  • 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide
  • I06-1873
  • SR-05000001532-1
  • SR-05000001532-2
  • SR-05000001532-4
  • BRD-K74763371-002-04-0
  • 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide
  • Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)(2,2'-bipyrimidin)-4-yl)-
  • N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]-4-tert-butyl-benzenesulfonamide
  • Z1530532762
  • 4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide
  • Bosentan, 99%, a endothelin (ET) receptor antagonist - 10mg 10mg
  • 1174918-31-0
  • 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl]benzene-1-sulfonamide
  • 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide
  • 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide
  • 4-tert-butyl-N-[6-(2-hydroxyethyloxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide
  • 1065472-77-6
  • 4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2''-bipyrimidin)-4-yl) benzenesulfornamide
  • 4-(1,1-Dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2 -bipyrimidin-4-yl]benzenesulfonamide
  • 4-(1,1-dimethylethyl)-n-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide
  • 4-(t-Butyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benZenesulfonamide
  • 4-(tert-Butyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide
  • 4-(tert-Butyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide
  • 4-tert butyl-N-[4-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)pyrimidin-6-yl]benzenesulphonamide
  • 4-tert-butyl-n-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide
  • 4-tert-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)benzene-1-sulfonamide
  • 4-tert-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl)benzenesulfonamide
  • 4-tert-butyl-N-[5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-6-(1,1,2,2-tetradeuterio-2-hydroxyethoxy)pyrimidin-4-yl]benzenesulfonamide
  • 4-tert-Butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-[2,2']bipyrimidinyl-4-yl]-benzenesulfonamide
  • 4-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2 -bipyrimidin-4-yl]benzenesulfonamide
  • 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2''-bipyrimidin-4-yl]benzenesulfonamide
  • 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide
  • 4-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzenesulfonamide
  • 4-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2 -bipyrimidine]-4-yl]benzenesulfonamide
  • 4-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzene-1-sulfonamide
  • Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-; 4-(1,1-Dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide; ACT 434964; Actelion; Bosentan; Ro 47-0203; Ro 47-0203/039; Tracleer; p-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl]benzenesulfonamide
  • K86